Nextcure Inc share price logo

Nextcure Inc Share Price

NASDAQ: NXTC

Small Cap

$5.73

+0.07

(+1.15%)

as on

Nextcure Inc Stock Performance

as on September 18, 2025 at 1:27 am IST

  • Day's Low

    Day's High

    $5.5
    $5.79
    downward going graph

    4.01%

    Downside

    1.05%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $2.69
    $19.2
    downward going graph

    53.09%

    Downside

    235.08%

    Upside

    downward going graph

Nextcure Inc share price movements today

Previous Close
$5.67
Open
$5.60
Volume
74.3K
Day's Low - High
$5.5 - $5.79
52 Week Low - High
$2.69 - $19.2

Nextcure Inc Historical Returns

1 Month Return
+ 5.51 %
3 Month Return
+ 2.19 %
1 Year Return
-66.96 %
3 Year Return
-88.05 %
5 Year Return
-95.17 %

Nextcure Inc Stock Fundamentals & Key Indicators

Check Nextcure Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$14.9M

EPS (TTM)

-15.5867

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

P/B Ratio

0

PEG Ratio

0

EBITDA

-61.2M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

35994200.00%

Nextcure Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Nextcure Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$14.9M-95.17%NA0.00%
BUY$60.5B248.74%-505.15-12.96%
NA$38.7BNANA-3.89%
BUY$99.3B45.88%27.5631.86%
BUY$60.9B5.45%14.4931.37%

Stock Returns calculator for Nextcure Inc Stock including INR - Dollar returns

The Nextcure Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Nextcure Inc investment value today

Current value as on today

₹38,705

Returns

₹61,295

(-61.29%)

Returns from Nextcure Inc Stock

₹65,893 (-65.89%)

Dollar Returns*

₹4,598 (+4.6%)

Analyst Recommendation on Nextcure Inc Stock

Based on 10 analysts

BUY

80.00%

Buy

20.00%

Hold

0.00%

Sell

Based on 10 analysts, 80% of analysts recommend a 'BUY' rating for Nextcure Inc. Average target price of $17.5

Nextcure Inc Share Price Target

Get share price movements and forecasts by analysts on Nextcure Inc.

What analysts predicted

67.26%UPSIDE

Target Price

$17.5

Current Price

$5.73

Analyzed by

10 Analysts

Target

$17.50

Nextcure Inc target price $17.5, a slight upside of 67.26% compared to current price of $5.73. According to 10 analysts rating.

Nextcure Inc Stock's Interest Amongst Investors

Search interest for Nextcure Inc Stock has decreased by -69% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-69% versus previous 30 day period

Nextcure Inc Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
-
-
-
6
-
-
-
3
-
-
Gross Profit
-1
-1
0
5
0
0
0
1
0
0
Operating Income
-17
-19
-15
-15
-15
-16
-12
-12
-11
-27
EBITDA
-16
-18
-14
-14
-14
-15
-11
-11
-10
-27
Interest Expense
0
-
-
0
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-16
-17
-14
-14
-17
-15
-11
-11
-10
-26
Income Tax Expense
0
0
0
0
0
-
-
-
-
-
Net Income
-15
-17
-14
-14
-17
-15
-11
-11
-10
-26
Net Profit Margin
0.00%
0.00%
0.00%
-230.22%
0.00%
0.00%
0.00%
-353.53%
0.00%
0.00%

Nextcure Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
-
-
6
22
-
-
-
-
Gross Profit
0
-1
6
22
-4
-4
-3
-2
Operating Income
-15
-23
-37
-41
-70
-75
-67
-59
EBITDA
-14
-21
-34
-37
-65
-71
-59
-54
Interest Expense
-
-
0
0
0
5
-
-
Depreciation
0
1
2
3
7
4
3
2
Income Before Tax
-15
-22
-33
-36
-69
-74
-62
-55
Income Tax Expense
-
0
2
-3
6
-5
-
-
Net Income
-15
-22
-33
-33
-69
-69
-62
-55
Net Profit Margin
0.00%
0.00%
-531.54%
-148.32%
0.00%
0.00%
0.00%
0.00%

Nextcure Inc Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-17
-14
-14
-17
-15
-11
-11
-10
-26
Operating Cash Flow
-14
-12
-10
-12
-9
-11
-6
-12
-22
Investing Cash Flow
6
10
4
17
12
18
6
7
3
Financing Cash Flow
0
-
0
0
0
0
0
-
2
Change in Cash
-7
-2
-6
5
2
6
0
-5
-16

Nextcure Inc Annual Cash Flow

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-22
-33
-36
-69
-74
-62
-55
Operating Cash Flow
7
-35
-44
-57
-53
-52
-40
Investing Cash Flow
-3
-303
43
36
67
39
55
Financing Cash Flow
121
243
-1
-3
0
0
0
Change in Cash
126
-96
-2
-23
14
-13
14

Global Institutional Holdings in Nextcure Inc

Funds
Holdings
Sofinnova Ventures
8.32%
Affinity Asset Advisors, LLC
7.17%
Pfizer Inc
5.89%
Citigroup Inc
4.42%
Orbimed Advisors, LLC
3.55%

Insights on Nextcure Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Beone Medicines Ltd has given 68.4% return, outperforming this stock by 135.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 111.5% return, outperforming this stock by 199.5%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 year, NXTC stock has moved down by -67.0%

About Nextcure Inc

nextcure, inc., a clinical-stage biopharmaceutical company, engages in discovering and developing novel immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. its lead product candidate is nc318, which is in phase 2 clinical trials for the treatment of advanced or metastatic solid tumors. the company is also developing nc410, is a novel immunomedicine designed to block immune suppression mediated by an immune modulator called leukocyte-associated immunoglobulin-like receptor 1. its discovery and research programs include an antibody in preclinical evaluation of other potential novel immunomodulatory molecules that targets a novel member of the b7-family of immunomodulatory proteins; and an antibody in preclinical development targeting an immune modulator that is expressed in inflamed tissue and the tumor microenvironment in various tumor types. nextcure, inc. has a license agreement with yale university; and a research and development col
OrganisationNextcure Inc
Headquarters9000 Virginia Manor Road, Beltsville, MD, United States, 20705
IndustryBiotechnology
CEOMr. Michael S. Richman MSBA
E-voting on sharesClick here to vote

Key Management of Nextcure Inc

Name

Title

Dr. Sebastien Maloveste Ph.D.

Senior Vice President of Business Development

Dr. Udayan Guha M.D., Ph.D.

Chief Medical Officer

Mr. Michael S. Richman MSBA

Co-Founder, CEO, President & Director

Dr. Timothy Mayer Ph.D.

Chief Operating Officer

Dr. Lieping Chen M.D., Ph.D.

Co-Founder & Chairman of Scientific Advisory Board

Mr. Steven P. Cobourn CPA

Chief Financial Officer

Mr. Kevin G. Shaw

Senior VP & General Counsel

Mr. Sourav Kundu Ph.D.

Senior Vice President of Development & Manufacturing

FAQs

What is Nextcure Inc share price today?

Nextcure Inc share price today is $5.73 as on at the close of the market. Nextcure Inc share today touched a day high of $5.79 and a low of $5.5.

What is the 52 week high and 52 week low for Nextcure Inc share?

Nextcure Inc share touched a 52 week high of $19.2 on and a 52 week low of $2.69 on . Nextcure Inc stock price today i.e. is closed at $5.73,which is 70.16% down from its 52 week high and 113.17% up from its 52 week low.

What is Nextcure Inc's market capitalisation today?

Nextcure Inc market capitalisation is $0.00T as on .

How to invest in Nextcure Inc Stock (NXTC) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Nextcure Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Nextcure Inc Shares that will get you 0.2618 shares as per Nextcure Inc share price of $5.73 per share as on September 18, 2025 at 1:27 am IST.

What is the minimum amount required to buy Nextcure Inc Stock (NXTC) from India?

Indian investors can start investing in Nextcure Inc (NXTC) shares with as little as ₹87.816 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹878.16 in Nextcure Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Nextcure Inc share’s latest price of $5.73 as on September 18, 2025 at 1:27 am IST, you will get 1.7452 shares of Nextcure Inc. Learn more about fractional shares .

What are the returns that Nextcure Inc has given to Indian investors in the last 5 years?

Nextcure Inc stock has given -95.17% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?